Zillow Group, Inc. ZG
8 trading plans running, 60 Form 144 notices for $15.8M
10-Q, 10-K and Form 144What ZG's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Mar 13, 2025 to Aug 18, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Dan Spaulding Chief People Officer |
Adopted 10b5-1 plan | Aug 28, 2026 | 10-Q Nov 4, 2026 | ||
What the company wroteOn August 28, 2026, Dan Spaulding, Chief People Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for (1) the sale of up to 258,287 shares of Class C capital stock related to the exercise of option awards granted to Mr. Spaulding and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Spaulding. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock units is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on November 27, 2026 and will terminate on August 18, 2028, subject to earlier termination as provided in the plan. | |||||
| Claire Cormier Thielke member of the Board |
Adopted 10b5-1 plan | May 12, 2026 | 10-Q Aug 5, 2026 | ||
What the company wroteOn May 12, 2026, Claire Cormier Thielke, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Ms. Thielke. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan. This 10b5-1 sales plan will become effective on August 11, 2026 and will terminate on March 3, 2027, subject to earlier termination as provided in the plan. | |||||
| Amy Bohutinsky member of the Board |
Adopted 10b5-1 plan | Mar 6, 2026 | 10-Q May 6, 2026 | ||
What the company wroteOn March 6, 2026, Amy Bohutinsky, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of up to 105,884 shares of Class C capital stock related to the exercise of option awards granted to Ms. Bohutinsky. This 10b5-1 sales plan will become effective on June 8, 2026 and will terminate on March 7, 2027, subject to earlier termination as provided in the plan. | |||||
| Erik Blachford member of the Board |
Adopted 10b5-1 plan | Mar 4, 2026 | 10-Q May 6, 2026 | ||
What the company wroteOn March 4, 2026, Erik Blachford, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Blachford. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan. This 10b5-1 sales plan will become effective on June 8, 2026 and will terminate on March 4, 2027, subject to earlier termination as provided in the plan. | |||||
| Jeremy Wacksman Chief Executive Officer |
Adopted 10b5-1 plan | Feb 20, 2026 | 10-Q May 6, 2026 | ||
What the company wroteOn February 20, 2026, Jeremy Wacksman, Chief Executive Officer of the Company and member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Wacksman. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on May 22, 2026 and will terminate on February 20, 2027, subject to earlier termination as provided in the plan. | |||||
| Lloyd D. Frink co-founder, President of the Company, and Co-Executive Chairman of the Board |
Adopted 10b5-1 plan | Feb 11, 2026 | 10-Q May 6, 2026 | ||
What the company wroteOn February 11, 2026, Lloyd D. Frink, co-founder, President of the Company, and Co-Executive Chairman of the Board, terminated a previously disclosed 10b5-1 sales plan that was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and was entered into on December 11, 2024. The 10b5-1 sales plan provided for an aggregate sale of (i) up to 200,000 shares of Class C capital stock plus (ii) up to an additional 200,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Frink. | |||||
| Richard N. Barton co-founder and Co-Executive Chairman of the Board |
Adopted 10b5-1 plan | Feb 11, 2026 | 10-Q May 6, 2026 | ||
What the company wroteOn February 11, 2026, Richard N. Barton, co-founder and Co-Executive Chairman of the Board, terminated a previously disclosed 10b5-1 sales plan that was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and was entered into on December 11, 2024. The 10b5-1 sales plan provided for the sale of up to 300,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Barton. On February 27, 2026, Mr. Barton entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan was amended on March 5, 2026 and provides for an aggregate sale of (i) up to 300,000 shares of Class C capital stock plus (ii) up to an additional 163,980 shares of Class C capital stock related to the exercise of option awards granted to Mr. Barton. This 10b5-1 sales plan will become effective on June 8, 2026 and will terminate on June 7, 2027, subject to earlier termination as provided in the plan. | |||||
| Jeremy Hofmann Chief Financial Officer |
Adopted 10b5-1 plan | Nov 19, 2025 | 10-K Feb 11, 2026 | ||
What the company wroteOn November 19, 2025, Jeremy Hofmann, Chief Financial Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for (1) the sale of up to 100,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Hofmann and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Hofmann. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on February 17, 2026 and will terminate on February 16, 2027, subject to earlier termination as provided in the plan. | |||||
| Bradley D. Owens General Counsel and Corporate Secretary |
Adopted 10b5-1 plan | Aug 19, 2025 | 10-Q Oct 30, 2025 | ||
What the company wroteOn August 19, 2025, Bradley D. Owens, General Counsel and Corporate Secretary of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for (1) the sale of up to 470,670 shares of Class C capital stock related to the exercise of option awards granted to Mr. Owens and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Owens. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on November 19, 2025 and will terminate on August 19, 2027, subject to earlier termination as provided in the plan. | |||||
| Claire Cormier Thielke member of the Board |
Adopted 10b5-1 plan | Mar 13, 2025 | 10-Q May 7, 2025 | ||
What the company wroteOn March 13, 2025, Claire Cormier Thielke, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Ms. Thielke. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan. This 10b5-1 sales plan will become effective on June 11, 2025, and will terminate on March 4, 2026, subject to earlier termination as provided in the plan. | |||||
| Erik Blachford member of the Board |
Adopted 10b5-1 plan | Mar 7, 2025 | 10-Q May 7, 2025 | ||
What the company wroteOn March 7, 2025, Erik Blachford, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Blachford. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan. This 10b5-1 sales plan will become effective on June 9, 2025 and will terminate on March 4, 2026, subject to earlier termination as provided in the plan. | |||||
| Jun Choo Chief Operating Officer of the Company |
Ended 10b5-1 plan | Feb 28, 2025 | 10-Q May 7, 2025 | ||
What the company wroteOn February 28, 2025, Jun Choo, Chief Operating Officer of the Company, terminated a previously disclosed 10b5-1 sales plan that was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and was entered into on December 5, 2024. The 10b5-1 sales plan provided for the sale of up to 50,085 shares of Class C capital stock related to the exercise of option awards granted to Mr. Choo. No shares were sold under the plan prior to its termination. | |||||
| Jeremy Wacksman Chief Executive Officer of the Company and member of the Board |
Adopted 10b5-1 plan | Feb 13, 2025 | 10-Q May 7, 2025 | ||
What the company wroteOn February 13, 2025, Jeremy Wacksman, Chief Executive Officer of the Company and member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for (1) the sale of up to 147,609 shares of Class C capital stock related to the exercise of option awards granted to Mr. Wacksman and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Wacksman. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on May 16, 2025 and will terminate on February 27, 2026, subject to earlier termination as provided in the plan. | |||||
| Lloyd D. Frink co-founder, President of the Company, and Co-Executive Chairman of the Board |
Adopted 10b5-1 plan | Dec 11, 2024 | 10-K Feb 11, 2025 | ||
What the company wroteOn December 11, 2024, Lloyd D. Frink, co-founder, President of the Company, and Co-Executive Chairman of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for an aggregate sale of (i) up to 200,000 shares of Class C capital stock plus (ii) up to an additional 200,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Frink. This 10b5-1 sales plan will become effective on April 14, 2025 and will terminate on March 12, 2026, subject to earlier termination as provided in the plan. | |||||
| Richard N. Barton co-founder and Co-Executive Chairman of the Board |
Adopted 10b5-1 plan | Dec 11, 2024 | 10-K Feb 11, 2025 | ||
What the company wroteOn December 11, 2024, Richard N. Barton, co-founder and Co-Executive Chairman of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of up to 300,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Barton. This 10b5-1 sales plan will become effective on April 1, 2025 and will terminate on March 25, 2026, subject to earlier termination as provided in the plan. | |||||
| Jun Choo Chief Operating Officer |
Adopted 10b5-1 plan | Dec 5, 2024 | 10-K Feb 11, 2025 | ||
What the company wroteOn December 5, 2024, Jun Choo, Chief Operating Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of up to 50,085 shares of Class C capital stock related to the exercise of option awards granted to Mr. Choo. This 10b5-1 sales plan will become effective on March 10, 2025 and will terminate on March 13, 2026, subject to earlier termination as provided in the plan. | |||||
| Jeremy Hofmann Chief Financial Officer |
Adopted 10b5-1 plan | Sep 4, 2024 | 10-Q Nov 6, 2024 | ||
What the company wroteOn September 4, 2024, Jeremy Hofmann, Chief Financial Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. This 10b5-1 sales plan provides for (1) the sale of up to 100,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Hofmann and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Hofmann. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on December 4, 2024 and will terminate on December 31, 2025, subject to earlier termination as provided in the plan. | |||||
| Dan Spaulding Chief People Officer |
Adopted 10b5-1 plan | Aug 30, 2024 | 10-Q Nov 6, 2024 | ||
What the company wroteOn August 30, 2024, Dan Spaulding, Chief People Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. This 10b5-1 sales plan provides for (1) the sale of up to 244,997 shares of Class C capital stock related to the exercise of option awards granted to Mr. Spaulding and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Spaulding. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on November 29, 2024 and will terminate on May 21, 2026, subject to earlier termination as provided in the plan. | |||||
| Claire Cormier Thielke member of the Board |
Adopted 10b5-1 plan | Jun 10, 2024 | 10-Q Aug 7, 2024 | ||
What the company wroteOn June 10, 2024, Claire Cormier Thielke, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for an aggregate sale of (i) 1,413 shares of Class C capital stock plus (ii) an indeterminate number of shares of Class C capital stock related to the future vesting of certain restricted stock units between September 1, 2024 and March 1, 2025. This 10b5-1 sales plan will become effective on September 16, 2024 and will terminate on March 4, 2025, subject to earlier termination as provided in this 10b5-1 sales plan. | |||||
| Erik Blachford member of the Board |
Adopted 10b5-1 plan | Mar 12, 2024 | 10-Q May 1, 2024 | ||
What the company wroteOn March 12, 2024, Erik Blachford, member of the Board of Zillow Group, Inc., entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to future vesting of restricted stock units. This 10b5-1 sales plan will become effective on June 11, 2024 and will terminate on March 3, 2025, subject to earlier termination as provided in the 10b5-1 sales plan. | |||||
| Jeremy Wacksman Chief Operating Officer |
Adopted 10b5-1 plan | Feb 16, 2024 | 10-Q Aug 7, 2024 | ||
What the company wroteIn addition, in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 1, 2024, the Company inadvertently omitted disclosure regarding the entry into a 10b5-1 sales plan by Jeremy Wacksman, Chief Operating Officer, on February 16, 2024. This 10b5-1 sales plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units. This 10b5-1 sales plan became effective on May 17, 2024 and will terminate on February 18, 2025, subject to earlier termination upon the sale of all shares of Class C capital stock subject to this 10b5-1 sales plan or as otherwise provided in this 10b5-1 sales plan. | |||||
| Jeremy Hofmann Chief Financial Officer |
Adopted 10b5-1 plan | Dec 11, 2023 | 10-K Feb 15, 2024 | ||
What the company wroteOn December 11, 2023, Jeremy Hofmann, Chief Financial Officer of Zillow Group, Inc., entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to future vesting of restricted stock units. This 10b5-1 sales plan will become effective on March 15, 2024 and will terminate on November 29, 2024, subject to earlier termination as provided in the 10b5-1 sales plan. | |||||
| Amy Bohutinsky Director |
Adopted 10b5-1 plan | Dec 4, 2023 | 10-K Feb 15, 2024 | ||
What the company wroteOn December 4, 2023, Amy Bohutinsky, Director of Zillow Group, Inc., entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the exercise of option awards and sale of up to 125,000 shares of Class A common stock and 270,625 shares of Class C capital stock. This 10b5-1 sales plan will become effective on March 4, 2024 and will terminate on January 7, 2025, subject to earlier termination upon the exercise of option awards and sale of all shares of Class A common stock or Class C capital stock subject to the 10b5-1 sales plan or as otherwise provided in this 10b5-1 sales plan. | |||||
| Brad Owens General Counsel |
Adopted 10b5-1 plan | Aug 21, 2023 | 10-Q Nov 1, 2023 | ||
What the company wroteOn August 21, 2023, Brad Owens, General Counsel, entered into a 10b5-1 sales plan (the “10b5-1 Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The 10b5-1 Sales Plan provides for the exercise of option awards and sale of up to 127,625 shares of Class C capital stock and the sale of an indeterminate number of shares of Class C capital stock related to future vesting of restricted stock units. The 10b5-1 Sales Plan will become effective on November 20, 2023 and will terminate on August 18, 2025, subject to earlier termination upon the exercise of option awards and sale of all shares of Class C capital stock subject to the 10b5-1 Sales Plan or as otherwise provided in the 10b5-1 Sales Plan. | |||||
Show the other 16 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 3, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 12, 2026 | Wacksman Jeremy Officer, Director |
5,989 | $176K |
| Nov 12, 2026 | Tremblay Rikki Officer |
1,065 | $31K |
| Nov 12, 2026 | Spaulding Dan Officer |
2,035 | $60K |
| Nov 12, 2026 | Samuelson Errol G Officer |
3,075 | $90K |
| Nov 12, 2026 | Rock Jennifer Former Affiliate |
1,655 | $48K |
| Nov 12, 2026 | Hofmann Jeremy Officer |
3,631 | $106K |
| Nov 12, 2026 | Beitel David A. Officer |
1,860 | $55K |
| Sep 3, 2026 | Cormier Thielke Claire Director |
1,187 | $42K |
| Sep 3, 2026 | BLACHFORD ERIK C Director |
792 | $28K |
| Aug 17, 2026 | Wacksman Jeremy Officer, Director |
9,339 | $319K |
| Aug 17, 2026 | Hofmann Jeremy Officer |
5,661 | $193K |
| Aug 14, 2026 | Owens Bradley D. Former Affiliate |
3,463 | $125K |
| Aug 14, 2026 | Spaulding Dan Officer |
3,169 | $112K |
| Aug 13, 2026 | Wacksman Jeremy Officer, Director |
5,786 | $198K |
| Aug 13, 2026 | Spaulding Dan Officer |
1,966 | $67K |
| Aug 13, 2026 | Samuelson Errol G Officer |
3,154 | $108K |
| Aug 13, 2026 | Rock Jennifer Officer |
990 | $34K |
| Aug 13, 2026 | Owens Bradley D. Former Affiliate |
2,148 | $74K |
| Aug 13, 2026 | Hofmann Jeremy Officer |
3,510 | $120K |
| Aug 13, 2026 | Choo Jun Former Affiliate |
1,617 | $55K |
| Aug 13, 2026 | Beitel David A. Officer |
1,798 | $62K |
| Aug 11, 2026 | Cormier Thielke Claire Director |
1,187 | $39K |
| Jun 8, 2026 | BLACHFORD ERIK C Director |
791 | $28K |
| May 22, 2026 | Wacksman Jeremy Officer, Director |
9,072 | $331K |
| May 18, 2026 | Spaulding Dan Officer |
3,078 | $115K |
| May 18, 2026 | Hofmann Jeremy Officer |
5,501 | $206K |
| May 15, 2026 | Owens Bradley D. Officer |
3,364 | $125K |
| May 14, 2026 | Wacksman Jeremy Officer, Director |
6,051 | $229K |
| May 14, 2026 | Spaulding Dan Officer |
2,056 | $78K |
| May 14, 2026 | Samuelson Errol G Officer |
2,939 | $112K |
| May 14, 2026 | Rock Jennifer Officer |
1,034 | $39K |
| May 14, 2026 | Owens Bradley D. Officer |
2,246 | $85K |
| May 14, 2026 | Hofmann Jeremy Officer |
3,671 | $139K |
| May 14, 2026 | Choo Jun Officer |
1,228 | $47K |
| May 14, 2026 | Beitel David A. Officer |
1,879 | $71K |
| Mar 26, 2026 | Samuelson Errol G Officer |
4,734 | $209K |
| Mar 24, 2026 | Owens Bradley D. Officer |
8,800 | $384K |
| Mar 3, 2026 | Cormier Thielke Claire Director |
242 | $10K |
| Mar 3, 2026 | BLACHFORD ERIK C Director |
966 | $41K |
| Feb 27, 2026 | MAFFEI GREGORY B Director |
8,050 | $363K |
| Feb 20, 2026 | Frink Lloyd D Officer, Director, Co -Exec. Chairman & President |
39,663 | $1.8M |
| Feb 18, 2026 | Hofmann Jeremy Officer |
7,786 | $340K |
| Feb 17, 2026 | Wacksman Jeremy Officer, Director |
13,661 | $605K |
| Feb 17, 2026 | Spaulding Dan Officer |
5,361 | $236K |
| Feb 13, 2026 | Owens Bradley D. Officer |
2,602 | $116K |
| Feb 12, 2026 | Wacksman Jeremy Officer, Director |
4,729 | $209K |
| Feb 12, 2026 | Spaulding Dan Officer |
3,901 | $172K |
| Feb 12, 2026 | Samuelson Errol G Officer |
7,015 | $310K |
| Feb 12, 2026 | Rock Jennifer Officer |
2,164 | $96K |
| Feb 12, 2026 | Owens Bradley D. Officer |
2,017 | $89K |
| Feb 12, 2026 | Hofmann Jeremy Officer |
5,538 | $245K |
| Feb 12, 2026 | Choo Jun Officer |
2,061 | $91K |
| Feb 12, 2026 | Beitel David A. Officer |
3,966 | $175K |
| Feb 9, 2026 | Frink Lloyd D Officer, Director, Co -Exec. Chairman & President |
84,168 | $4.6M |
| Dec 3, 2025 | Cormier Thielke Claire Director |
241 | $17K |
| Dec 3, 2025 | BLACHFORD ERIK C Director |
965 | $70K |
| Nov 19, 2025 | Owens Bradley D. Officer |
2,722 | $183K |
| Nov 14, 2025 | Wacksman Jeremy Officer, Director |
10,855 | $760K |
| Nov 14, 2025 | Spaulding Dan Officer |
5,455 | $379K |
| Nov 14, 2025 | Hofmann Jeremy Officer |
7,865 | $547K |
Show the other 52 notices
From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ZG/export.csv") into a cell.